Published in Hum Immunol on November 01, 1997
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07
CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog (2006) 1.45
The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta (2010) 1.40
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol (2001) 1.28
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflammation (2007) 1.15
CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates. J Virol (2002) 1.04
Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis. J Clin Immunol (1999) 0.93
Is the CCR5 Δ 32 mutation associated with immune system-related diseases? Inflammation (2013) 0.91
The genetic epidemiology of multiple sclerosis. Philos Trans R Soc Lond B Biol Sci (1999) 0.85
An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med Genet (2006) 0.78
CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population. Cell Mol Neurobiol (2009) 0.78
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis (2001) 6.32
Trends in infectious diseases mortality in the United States. JAMA (1996) 5.79
Inconsistencies in coding of race and ethnicity between birth and death in US infants. A new look at infant mortality, 1983 through 1985. JAMA (1992) 5.62
The effect of known risk factors on the excess mortality of black adults in the United States. JAMA (1990) 4.45
Poverty and death in the United States--1973 and 1991. Epidemiology (1995) 4.01
Priorities among recommended clinical preventive services. Am J Prev Med (2001) 3.70
The biology of natural transformation. Annu Rev Microbiol (1986) 3.46
Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 3.40
Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet (1979) 3.22
New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council. Med J Aust (1997) 2.69
Epidemic toxoplasmosis associated with infected cats. N Engl J Med (1979) 2.55
Excess deaths from nine chronic diseases in the United States, 1986. JAMA (1990) 2.25
Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 2.20
Prevalence of tuberculosis infection among primary school-entry children in Sydney. Aust N Z J Public Health (1996) 2.06
Methods for priority setting among clinical preventive services. Am J Prev Med (2001) 2.05
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Indirect cost of ischemic heart disease to employers. Am J Manag Care (2001) 2.03
Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet (1985) 1.96
The effectiveness of insecticide-impregnated bed nets in reducing cases of malaria infection: a meta-analysis of published results. Am J Trop Med Hyg (1995) 1.65
Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem (1981) 1.62
Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis (2000) 1.59
A framework for assessing the effectiveness of disease and injury prevention. MMWR Recomm Rep (1992) 1.53
Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia (1988) 1.49
Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol (1974) 1.48
Poverty and death in the United States. Int J Health Serv (1996) 1.47
The effects of endotoxin on vascular endothelium. J Exp Med (1969) 1.42
Radon and lung cancer: a cost-effectiveness analysis. Am J Public Health (1999) 1.42
SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens (2007) 1.38
Genetic exchange in the environment. Antonie Van Leeuwenhoek (1989) 1.38
Pneumonic tularemia on Martha's Vineyard. N Engl J Med (1979) 1.36
Increasing the supply of cadaveric kidneys for transplantation. Transplantation (1981) 1.35
Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. J Clin Epidemiol (1994) 1.35
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. Am J Prev Med (2001) 1.28
An approach to the prevention of blindness in diabetes. Diabetes Care (1984) 1.22
HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19
Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med (2000) 1.18
Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol (1975) 1.16
Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol (2000) 1.16
Gestational diabetes. Incidence, maternal characteristics, and perinatal outcome. Diabetes (1985) 1.16
Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med (1984) 1.12
Enzyme replacement in nervous tissue after allogeneic bone-marrow transplantation for fucosidosis in dogs. Lancet (1986) 1.12
Evidence for an active role of donor cells in natural transformation of Pseudomonas stutzeri. J Bacteriol (1983) 1.11
Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol (1994) 1.10
HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis. Ann Neurol (1978) 1.10
An epidemiologic model for diabetes mellitus: incidence, prevalence, and mortality. Diabetes Care (1984) 1.09
Infection and multiple sclerosis--a new hypothesis? J Neurol Neurosurg Psychiatry (2002) 1.08
The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett (1992) 1.08
Acquired toxoplasmosis. Ophthalmology (1982) 1.06
Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med (Berl) (2005) 1.06
The control of hypertension in persons with diabetes: a public health approach. Public Health Rep (1987) 1.06
Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation (1990) 1.05
Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. J Clin Epidemiol (2001) 1.05
An assessment of the POSSUM system in orthopaedic surgery. J Bone Joint Surg Br (2002) 1.04
Semen analysis in human immunodeficiency virus infection. Fertil Steril (1992) 1.03
Natural transformation in river epilithon. Appl Environ Microbiol (1996) 1.03
Motor-vehicle occupant injury: strategies for increasing use of child safety seats, increasing use of safety belts, and reducing alcohol-impaired driving. MMWR Recomm Rep (2001) 1.03
Screening and treating adults for lipid disorders. Am J Prev Med (2001) 1.02
A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun (2002) 1.01
Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis (1993) 0.99
Early events in the formation of a venous thrombus following local trauma and stasis. Lab Invest (1984) 0.99
Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells. J Exp Med (1980) 0.98
An improved method for the isolation of dense storage granules from human platelets. J Cell Biol (1978) 0.98
HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet (1997) 0.98
HLA-DW2, viral immunity and family studies in multiple sclerosis. J Neurol Sci (1977) 0.97
A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems. Early Hum Dev (1996) 0.96
Lymphocyte proliferative responsiveness in 31 patients after an outbreak of toxoplasmosis. Am J Trop Med Hyg (1979) 0.96
The effect of contrast media on normal and inflamed canine veins. A scanning and transmission electron microscopic study. Invest Radiol (1975) 0.96
Nonenzymatic polymerization of fibrinogen by protamine sulfate. An electron microscope study. Biochim Biophys Acta (1969) 0.96
Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet Gynecol (1988) 0.95
CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort. Autoimmunity (2002) 0.95
Changes in the ultrastructure and number of platelets induced by an adrenochrome complex. Thromb Diath Haemorrh (1970) 0.95
Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox). Blood (1984) 0.94
Characterization of Toxoplasma gondii isolates from an outbreak of toxoplasmosis in Atlanta, Georgia. Am J Vet Res (1981) 0.93
A transmission and scanning electron microscopic study of luminal surfaces in Dacron and autogenous vein bypasses in man and dog. Surgery (1973) 0.92
The role of hypercoagulability in thrombosis. Br J Haematol (1978) 0.92
The prevalence of risk factors among women in the United States by race and age, 1992-1994: opportunities for primary and secondary prevention. J Am Med Womens Assoc (1998) 0.92
Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg (1999) 0.91
Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun (2007) 0.91
An ultrastructural study of endotoxin induced damage in rabbit mesenteric arteries. Br J Exp Pathol (1971) 0.90
Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery (1989) 0.90
A scanning and transmission electron microscope study of the luminal coating on Dacron prostheses in the canine thoracic aorta. J Lab Clin Med (1975) 0.90
Toxoplasma gondii isolated from amniotic fluid. Obstet Gynecol (1980) 0.89
Reversal of succinate-mediated catabolite repression of alkylsulfatase in Pseudomonas aeruginosa by 2,4-dinitrophenol and by sodium malonate. Can J Microbiol (1978) 0.89
Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Exp Cell Res (1996) 0.88
The economic impact of obesity in the United States: whither? Obes Res (1998) 0.88
Mammography use and outcomes in a community. The Greater Lansing Area Mammography Study. Cancer (1993) 0.87
The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients. Hum Immunol (1999) 0.87
Effectiveness of postmigration screening in controlling tuberculosis among refugees: a historical cohort study, 1984-1998. Am J Public Health (2001) 0.87
Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs. Am J Med Genet (1992) 0.87
Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis. J Pediatr (1996) 0.87
Aggregation of platelets and cell membrane vesiculation by rat cells transformed in vitro by Rous sarcoma virus. Cancer Res (1978) 0.87